Analgesic effect of fentanyl combined with dexmedetomidine and parexib sodium in wound dressing change

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027965

Enrollment

Unknown

Registered

2019-12-07

Start date

2019-12-06

Completion date

Unknown

Last updated

2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Interventions

A:fentanyl

B:Fentanyl combined with dexmedetomidine

C:fentanyl combined with dexmedetomidine and parexib sodium

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged between 18 and 65 years; Wound area: > 5%

Exclusion criteria

Exclusion criteria: Heart rate below 60 beats/min; Blood pressure below 90/60mmhg; Allergy to analgesics and sedatives; Concomitant craniocerebral disease; Arrhythmia, conduction block; Chronic respiratory disease, chronic hypoxia.

Design outcomes

Primary

Measure	Time frame
VAS;RASS;blood pressure;electrocardiogram monitoring;Breathe;oxyhemoglobin saturation;	—

Countries

China

Contacts

Public ContactGuangtao Huang

The First Affiliated Hospital of Zunyi Medical University

haitao3140@sina.com+86 18085287828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026